Uses of pegylated albumin

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C530S350000, C530S362000, C424S009100

Reexamination Certificate

active

08071546

ABSTRACT:
The present invention is directed to uses of PEGylated albumins which include methods of treating reduced functional capillary density, reduced blood volume, septic shock and cardiac arrhythmia in a subject, which comprise administering to the subject a therapeutically effective amount of a PEGylated albumin.

REFERENCES:
patent: 5585484 (1996-12-01), Acharya et al.
patent: 5750725 (1998-05-01), Acharya et al.
patent: 6017943 (2000-01-01), Acharya et al.
patent: 6371975 (2002-04-01), Cruise et al.
patent: 6458147 (2002-10-01), Cruise et al.
patent: 6670323 (2003-12-01), Looker et al.
patent: 6773613 (2004-08-01), Winslow et al.
patent: 6844317 (2005-01-01), Winslow et al.
patent: 6875423 (2005-04-01), Intaglietta et al.
patent: 7019117 (2006-03-01), Acharya et al.
patent: 7038016 (2006-05-01), Talarico et al.
patent: 7144989 (2006-12-01), Acharya et al.
patent: 7169900 (2007-01-01), Acharya et al.
patent: 7271145 (2007-09-01), Winslow et al.
patent: 7501499 (2009-03-01), Acharya et al.
patent: 7521174 (2009-04-01), Acharya et al.
patent: 2003/0009145 (2003-01-01), Struijker-Boudier et al.
patent: 2003/0161809 (2003-08-01), Houston et al.
patent: 2004/0002443 (2004-01-01), Acharaya et al.
patent: 2005/0026816 (2005-02-01), Winslow et al.
patent: 2005/0037966 (2005-02-01), Ruben et al.
patent: 2005/0159339 (2005-07-01), Acharya et al.
patent: 2005/0201988 (2005-09-01), Acharya et al.
patent: 2006/0111275 (2006-05-01), Acharaya et al.
patent: 2009/0215670 (2009-08-01), Acharya et al.
patent: 2009/0298746 (2009-12-01), Acharya et al.
patent: 2010/0216695 (2010-08-01), Acharya et al.
patent: WO 2006/135740 (2006-12-01), None
patent: WO 2007/050121 (2007-05-01), None
Wettstein R et al., entitled “Resuscitation from Hemorrhagic Shock with MalPEG-Albumin: Comparison with MalPEG-Hemoglobin,” Shock, vol. 22, No. 4, 2004, pp. 351-357.
“PCT Notification Concerning Transmittal of International Preliminary Report on Patentability” dated Mar. 19, 2009 issued by The International Bureau of WIPO in connection with PCT International Patent Application No. PCT/US2006/022619, 8 pages, Mar. 19, 2009.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Uses of pegylated albumin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Uses of pegylated albumin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Uses of pegylated albumin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4295885

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.